2015
Use of outcome measures in pulmonary hypertension clinical trials
Parikh KS, Rajagopal S, Arges K, Ahmad T, Sivak J, Kaul P, Shah SH, Tapson V, Velazquez EJ, Douglas PS, Samad Z. Use of outcome measures in pulmonary hypertension clinical trials. American Heart Journal 2015, 170: 419-429.e3. PMID: 26385024, DOI: 10.1016/j.ahj.2015.06.010.Peer-Reviewed Original ResearchConceptsHypertension clinical trialsPulmonary arterial hypertensionPAH trialsClinical practiceInvasive hemodynamicsPrimary endpointClinical trialsOutcome measuresInvasive measuresSurrogate measureDuke University Medical CenterPatient-centered endpointsSecondary outcome measuresClinical treatment trialsMEDLINE/EMBASEUniversity Medical CenterSmall patient populationQuality of lifeContemporary clinical practicePAH therapyPH medicationsArterial hypertensionSerial echocardiographyPatient characteristicsSecondary outcomes
2014
Factors Associated With Isolated Right Heart Failure in Women A Pilot Study From Western Kenya
Lagat DK, DeLong AK, Wellenius GA, Carter EJ, Bloomfield GS, Velazquez EJ, Hogan J, Kimaiyo S, Sherman CB. Factors Associated With Isolated Right Heart Failure in Women A Pilot Study From Western Kenya. Global Heart 2014, 9: 249-254. PMID: 25667096, PMCID: PMC4405788, DOI: 10.1016/j.gheart.2014.04.003.Peer-Reviewed Original ResearchConceptsRight heart failureOccupational dust exposureAirflow limitationHeart failureControl subjectsIndoor air pollutionDust exposureIsolated right heart failureHuman immunodeficiency virus (HIV) testingPilot studySmall observational studiesCase-control studyKitchen ventilationSpecific environmental exposuresWestern KenyaSurrogate measureA Pilot StudyAnalysis of subgroupsSmoke exposure timeExpiratory volumeHIV positivityReferral hospitalWalk testOccupational dustThromboembolic disease